Examqo › Examqo library › Cardiothoracic surgery › Benign and end-stage lung disease · IMLE
Lung transplantation — the basics
Lung transplantation is for a patient with end-stage lung disease who is expected to die from it despite optimal treatment and has no contraindications; the main indications are ILD (mostly IPF), COPD, CF and PAH, the lethal early complication is primary graft dysfunction, and the main late complication is chronic rejection (CLAD/BOS).
Why it matters in the exam
The exam asks when to refer, who is not a candidate, which type of transplant fits and which complication fits the period. In ILD referral is early — already at diagnosis of IPF — because the disease progresses fast; in COPD the BODE index is used, and referral fits from a BODE of 5 or more. In CF and bronchiectasis a bilateral transplant is mandatory, because a remaining infected lung would contaminate the graft. Contraindications according to ISHLT 2021 include active or recent cancer, a BMI of 35 or more, active smoking or substance use, uncontrolled infection, significant failure of another organ and non-adherence.
Complications by time: in the first 72 hours — primary graft dysfunction (PGD), non-cardiogenic pulmonary oedema and impaired oxygenation; in the first weeks — bronchial anastomotic complications (because the bronchial arteries are not reconnected), acute rejection diagnosed by transbronchial biopsy, and infections (CMV is the commonest opportunistic infection, and also Aspergillus). Late — chronic rejection (CLAD), defined as a persistent fall of 20% or more in FEV1 from the best baseline value, and the leading cause of death after the first year; and post-transplant lymphoproliferative disease (PTLD) linked to EBV. Typical immunosuppression combines tacrolimus, mycophenolate and steroids, and median survival is only about 6 years — lower than after other organ transplants.
Remember also that a patient with severe PAH and irreversible right heart failure may need a heart-lung transplant. After transplant the patient stays under close lifelong follow-up, with home spirometry and periodic tests, to detect rejection and infection early.
Key points
- Main indications: ILD, COPD, CF, PAH.
- CF and bronchiectasis — bilateral only.
- BMI of 35 or more — a contraindication.
- PGD early; CLAD late.
- CMV is the commonest opportunistic infection.
Summary table
| Period | Complication | Key points |
|---|---|---|
| First 72 hours | Primary graft dysfunction (PGD) | Main cause of early death |
| First weeks | Bronchial anastomotic complication | No bronchial arterial supply |
| First months | Acute rejection | Transbronchial biopsy; steroids |
| Any time | Infections — CMV, Aspergillus | Prophylaxis and monitoring |
| Late | CLAD/BOS | A fall of 20% or more in FEV1; leading cause of late death |
A free exam question
בת 55, כחודש לאחר השתלת כליה. מתאשפזת עם עליה בקריאטנין מ- 0.9 מ"ג/ד"ל ל- 2.5 מ"ג/ד"ל ופרוטאינוריה חדשה. בביופסיה Acute cellular rejection . בדם נמצאו רמות שפל של Tacrolimus מתחת לסף הגילוי. מה יכולה להיות הסיבה הסבירה ביותר ? (the question as examined, in Hebrew)
- א. התחלת טיפול ב- Verapamil בשבועיים האחרונים בשל פרפור פרוזדורים
- ב. חידוש טיפול ב- Carbamazepine שהופסק סביב ניתוח ההשתלה
- ג. טיפול ב- Erythromycin לפני שבוע בשל דימום ממערכת העיכול העליונה
- ד. טיפול ב- Ketoconazole לפני שבוע לזיהום פטרייתי בציפורניים
In the full version for subscribers
- A simple algorithm
- Memory aid
- Exam traps
- 5 review cards
- Enough for IMLE
The full version is open to subscribers of: Cardiothoracic surgery, General surgery, Internal medicine, Medical licensing exam (IMLE).
Subscriber? Read the full topic Plans and prices 25 free questions
Sources
- ISHLT consensus document for the selection of lung transplant candidates, 2021 — Referral, listing and contraindications
- ISHLT consensus report: Chronic lung allograft dysfunction, 2019 — Definition, diagnostic criteria and grading
- ISHLT International Thoracic Organ Transplant Registry report, 2019 — Adult lung transplantation
Sources are given for further reading; the text is written afresh and not copied from them.
Reviewed by the Examqo AI Professor · 2026-11-06. The text may contain errors; when in doubt, check the source.